# Study of Human Bone Marrow Mesenchymal Stem Cells in APAP

> **NCT06111846** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Autoimmune Pulmonary Alveolar Proteinosis

## Interventions

- **DRUG:** human Bone Marrow Mesenchymal Stem Cell (hBMMSC)

## Key facts

- **NCT ID:** NCT06111846
- **Lead sponsor:** Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-12-25
- **Primary completion:** 2025-07-22
- **Final completion:** 2026-08-30
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06111846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06111846, "Study of Human Bone Marrow Mesenchymal Stem Cells in APAP". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06111846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*